Skip to main content

Table 2 Description of corticosteroid therapy among 183 critically ill patients with COVID-19

From: Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study

 

Total, n = 183

Dexamethasonea

4 (2%)

Hydrocortisonea

11 (6%)

Methylprednisolonea

175 (96%)

Prednisonea

3 (2%)

Duration of corticosteroid treatment, day

9 (5–14)

Hydrocortisone equivalents per ICU day, mg/day

200 (100–320.9)

Duration between hospital admission and corticosteroid initiation, day

1 (0–5)

Duration between ICU admission and corticosteroid initiation, day

0 (0–2)

Duration between onset of ventilation and corticosteroid initiation, day

0 (0–4)

PaO2/FiO2 when corticosteroid initiation, mmHg

119 (82, 200)

SOFA score when corticosteroid initiation

4 (3, 6)

  1. Q quartile, SOFA Sequential Organ Failure Assessment
  2. aPercentages of dexamethasone, hydrocortisone, methylprednisolone and prednisone add to more than 100% because some patients received one or more formulation of corticosteroids. Data presented as n (%) or median (Q1–Q3)
Back to article page

Critical Care

ISSN: 1364-8535